China Regenerative Medicine International Limited (HKG:8158)
Hong Kong · Delayed Price · Currency is HKD 0.1800
-0.0180 (-9.09%)
Aug 28, 2026, 3:24 PM HKT
HKG:8158 Market Cap
HKG:8158 has a market cap or net worth of 54.77 million as of August 28, 2026. Its market cap has decreased by -78.05% in one year.
Market Cap
54.77M
Enterprise Value
6.32M
Revenue
86.40M
Ranking
n/a
PE Ratio
1.99
Stock Price
0.18
ChartMarket Cap Chart
Since July 18, 2001, HKG:8158's market cap has decreased from 67.20M to 54.77M, a decrease of -18.50%. That is a compound annual growth rate of -0.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 54.77M | -57.14% |
| Dec 31, 2025 | 127.79M | 42.37% |
| Dec 31, 2024 | 89.75M | -46.36% |
| Dec 29, 2023 | 167.34M | -47.18% |
| Dec 30, 2022 | 316.83M | -60.36% |
| Dec 31, 2021 | 799.20M | -50.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kintor Pharmaceutical | 822.19M |
| Cutia Therapeutics | 710.38M |
| Brii Biosciences | 692.93M |
| Wuhan YZY Biopharma | 639.70M |
| 3D Medicines | 638.16M |
| B&K Corporation | 574.17M |
| Shanghai Bio-heart Biological Technology | 535.52M |
| Transcenta Holding | 479.98M |